SPEED REGULATORY APPROVAL WITH ACCURATE LUNG SAFETY DATA IMPROVE THE QUALITY OF RESPIRATORY DATA FOR YOUR CLINICAL TRIAL While many sponsors rely on ERT Respiratory solutions to prove subtle efficacy effects in compounds for the treatment of diseases such as asthma, COPD and idiopathic pulmonary fibrosis, we also optimize the centralized collection and analysis of respiratory data to accurately measure lung safety and disease progression in non-respiratory therapy areas. Monitor lung safety in non-respiratory therapy areas The importance of pulmonary safety monitoring in clinical research is increasing with novel developments in drug delivery. Adverse pulmonary reactions to pharmacotherapy can occur if the lungs serve as the entry route into the body for inhaled compounds to tr

Join for free to read